TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Mar 2025

Income Metrics

Revenue 1.4B
Gross Profit 572.4M 42.15%
Operating Income 197.7M 14.56%
Net Income 48.4M 3.56%
EPS (Diluted) $0.10

Balance Sheet Metrics

Total Assets 26.2B
Total Liabilities 15.4B
Shareholders Equity 10.8B
Debt to Equity 1.42

Cash Flow Metrics

Operating Cash Flow 352.0M
Free Cash Flow 203.4M

Revenue & Profitability Trend

Ventas Income Statement From 2020 to 2024

Metric20242023202220212020
Revenue i4.9B4.5B4.1B3.8B3.8B
Cost of Goods Sold i2.8B2.6B2.3B2.1B1.9B
Gross Profit i2.1B1.9B1.8B1.7B1.9B
Gross Margin % i42.6%43.1%44.7%45.4%48.9%
Operating Expenses
Research & Development i-----
Selling, General & Administrative i163.0M148.9M144.9M129.8M130.2M
Other Operating Expenses i-----
Total Operating Expenses i163.0M148.9M144.9M129.8M130.2M
Operating Income i681.2M415.5M483.8M421.4M591.4M
Operating Margin % i13.8%9.2%11.7%11.0%15.6%
Non-Operating Items
Interest Income i-----
Interest Expense i602.8M574.1M467.6M440.1M469.5M
Other Non-Operating Income-27.8M118.8M-74.1M80.0M222.8M
Pre-tax Income i50.6M-39.8M-57.9M61.4M344.7M
Income Tax i-37.8M-9.5M-16.9M4.8M-96.5M
Effective Tax Rate % i-74.7%0.0%0.0%7.9%-28.0%
Net Income i88.4M-30.3M-40.9M56.6M441.2M
Net Margin % i1.8%-0.7%-1.0%1.5%11.6%
Key Metrics
EBITDA i1.9B1.9B1.6B1.6B1.7B
EPS (Basic) i$0.20$-0.10$-0.12$0.13$1.18
EPS (Diluted) i$0.19$-0.10$-0.12$0.13$1.17
Basic Shares Outstanding i411770000401809000399549000382785000373368000
Diluted Shares Outstanding i411770000401809000399549000382785000373368000

Income Statement Trend

Ventas Balance Sheet From 2020 to 2024

Metric20242023202220212020
Assets
Current Assets
Cash & Equivalents i897.8M508.8M122.6M149.7M413.3M
Short-term Investments i---0237.6M
Accounts Receivable i202.7M194.1M187.5M176.9M169.7M
Inventory i-----
Other Current Assets-----
Total Current Assets i1.4B868.2M964.6M951.0M1.5B
Non-Current Assets
Property, Plant & Equipment i-----
Goodwill i2.1B2.1B2.1B2.1B2.1B
Intangible Assets i11.5M5.6M6.4M7.3M4.7M
Long-term Investments40.2M59.3M23.6M48.9M50.1M
Other Non-Current Assets416.5M319.7M283.1M250.6M234.4M
Total Non-Current Assets i24.8B23.9B23.2B23.8B22.4B
Total Assets i26.2B24.7B24.2B24.7B23.9B
Liabilities
Current Liabilities
Accounts Payable i1.2B1.0B1.0B1.1B1.1B
Short-term Debt i6.4M14.0M428.2M336.4M193.5M
Current Portion of Long-term Debt-----
Other Current Liabilities2.7M9.2M6.5M10.8M3.2M
Total Current Liabilities i1.3B1.2B1.6B1.5B1.4B
Non-Current Liabilities
Long-term Debt i13.7B13.7B12.1B11.9B11.9B
Deferred Tax Liabilities i8.2M24.5M35.6M59.3M62.6M
Other Non-Current Liabilities-----
Total Non-Current Liabilities i14.1B14.0B12.4B12.2B12.2B
Total Liabilities i15.4B15.2B13.9B13.8B13.7B
Equity
Common Stock i109.1M100.6M99.9M99.8M93.6M
Retained Earnings i---5.4B-4.7B-4.0B
Treasury Stock i25.2M13.8M536.0K00
Other Equity-----
Total Shareholders Equity i10.8B9.5B10.2B10.9B10.3B
Key Metrics
Total Debt i13.7B13.7B12.5B12.2B12.1B
Working Capital i46.8M-314.1M-612.4M-593.1M89.9M

Balance Sheet Composition

Ventas Cash Flow Statement From 2020 to 2024

Metric20242023202220212020
Operating Activities
Net Income i88.4M-30.3M-40.9M56.6M441.2M
Depreciation & Amortization i1.3B1.4B1.2B1.2B1.1B
Stock-Based Compensation i31.0M31.0M30.7M32.0M21.5M
Working Capital Changes i16.6M-54.8M-45.7M-37.8M121.6M
Operating Cash Flow i1.3B1.2B1.1B1.2B1.7B
Investing Activities
Capital Expenditures i-----
Acquisitions i-69.8M-80.5M-83.7M-129.3M-286.8M
Investment Purchases i-----
Investment Sales i-----
Investing Cash Flow i-184.7M-21.0M-99.8M219.6M-282.8M
Financing Activities
Share Repurchases i----96.0K-575.0K
Dividends Paid i-740.3M-723.6M-720.3M-686.9M-928.8M
Debt Issuance i1.9B2.5B957.8M1.5B733.3M
Debt Repayment i-1.6B-2.0B-575.4M-2.1B-479.5M
Financing Cash Flow i1.4B-545.5M-292.6M-566.7M-1.3B
Free Cash Flow i725.8M476.9M666.1M593.1M921.5M
Net Change in Cash i2.6B667.2M719.0M840.6M75.7M

Cash Flow Trend

Ventas Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 194.30
Forward P/E 400.75
Price to Book 2.52
Price to Sales 5.72
PEG Ratio 400.75

Profitability Ratios

Profit Margin 2.82%
Operating Margin 14.15%
Return on Equity 1.38%
Return on Assets 1.92%

Financial Health

Current Ratio 0.63
Debt to Equity 108.90
Beta 0.97

Per Share Data

EPS (TTM) $0.33
Book Value per Share $25.43
Revenue per Share $12.01

Peer Financial Comparison

CompanyMarket CapP/E RatioP/B RatioROEProfit MarginDebt/Equity
vtr28.9B194.302.521.38%2.82%108.90
Welltower 109.0B91.013.023.45%12.18%47.36
Omega Healthcare 12.5B25.482.4310.65%42.23%96.77
Healthpeak 12.0B72.131.522.14%5.90%109.01
CareTrust REIT 7.4B27.532.038.28%58.90%34.75
American Healthcare 6.9B-140.932.78-1.41%-1.53%69.74

Financial data is updated regularly. All figures are in the company's reporting currency.